Vinge has advised Isofol Medical AB (publ), First North Growth Market Premier, in connection with its rights issue in the total amount of MSEK 150 and, conditional upon oversubscription in respect of the rights issue, a directed new issue of shares of a total amount of MSEK 30.
Isofol has convened an extraordinary general meeting which is proposed to grant authority to the board of directors to adopt resolutions concerning the new issues of shares. The rights issue is fully underwritten through underwriting undertakings and guarantee obligations.
Vinge’s team primarily consisted of Anders Strid, Wibeke Sorling, Jenny Sandlund (all Capital Markets) as well as Victor Ericsson and Emelie Svanberg (Tax).
